造血干细胞移植后出血性膀胱炎  

Hemorrhagic Cystitis after Hematopoietic Stem Cell Transplantation

作　　者：王彦华[1] 李春富[1] 吴学东[1] 冯晓勤[1] 何岳林[1] 张玉明[1] 裴夫瑜[1] 

机构地区：[1]南方医科大学附属南方医院儿科,广州510515

出　　处：《实用儿科临床杂志》2012年第3期218-220,共3页Journal of Applied Clinical Pediatrics

摘　　要：造血干细胞移植(HSCT)已成为临床上治疗血液恶性或非恶性疾病的一种重要治疗手段,而出血性膀胱炎(HC)是HSCT后常见的并发症。其病因是不同的,因此常见的预防措施是必须的,但并不是都有效,可能需多种治疗措施联合应用。对于重度HC需要降低病死率。目前对于HC的研究尚未达成共识,制定出统一的规范化治疗方案。现综述HSCT后HC的病因、诊断、治疗及预防。The role of hematopoietic stem cell transplantation （HSCT） has been clearly defined for patients with hematological malignant or non - malignant diseases. Hemorrhagic cystitis （HC） is a well - known complication of HSCT. The etiology of haemorrhagic cystitis is va- fled. Prevention of haemoiThagic cystitis, based on general measures and specific measures, is essential, but is not always effective. In the case of proven haemorrhagic cystitis, various treatment options are available. Deaths are not exceptional, emphasizing the seriousness of hae- morrhagie cystitis. Unfortunately, there are no evidence - based on treatment guidelines for this clinical issue because of the leaking a consen- sus. Currently, the etiology of HC. diagnose, and therapeutic ontions, preventive methods are reviewed.

关 键 词：造血干细胞移植 出血性膀胱炎 病因 治疗 

分 类 号：R457[医药卫生—治疗学]